Insider holders · CIK 0001776111
MBX Biosciences, Inc. · MBX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Steven L. HoerterPresident and CEO | 82,938 | 20,000 | 102,938 | Aug 4, 2026 · 8:50 am EDT | Form 4 |
| John W SmitherChief Financial Officer | 28,000 | — | 28,000 | Aug 4, 2026 · 8:51 am EDT | Form 4 |
| Ora H. PescovitzDirector | 24,329 | — | 24,329 | Jun 5, 2026 · 7:59 am EDT | Form 4 |
| Salomon AzoulayChief Medical Officer | 14,399 | — | 14,399 | Aug 5, 2026 · 4:57 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.